Translumina launches Dual-Drug Polymer-free Coated Stent (DDCS)
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports
Subscribe To Our Newsletter & Stay Updated